The results from this three-year study suggest that Zepbound and Mounjaro may reduce the risk of developing diabetes by 94% among patients with pre-diabetes.
Dr. Jeff Emmick stated, 'These data reinforce the potential clinical benefits of long-term therapy for people living with obesity and pre-diabetes,' emphasizing the importance of sustained treatment.
In the study, patients using the highest dose of the drug lost over 22% of their body weight, showcasing the significant impact of GLP-1 drugs on weight loss.
Hormone-mimicking shots like Zepbound and Mounjaro make your body feel full with less food, improve blood sugar control and slow down digestion.
Collection
[
|
...
]